[go: up one dir, main page]

ES2167419T3 - Procedimiento de fabricacion de un epoxido. - Google Patents

Procedimiento de fabricacion de un epoxido.

Info

Publication number
ES2167419T3
ES2167419T3 ES95911105T ES95911105T ES2167419T3 ES 2167419 T3 ES2167419 T3 ES 2167419T3 ES 95911105 T ES95911105 T ES 95911105T ES 95911105 T ES95911105 T ES 95911105T ES 2167419 T3 ES2167419 T3 ES 2167419T3
Authority
ES
Spain
Prior art keywords
epoxide
manufacturing procedure
proteases
rhinine
halohidrine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95911105T
Other languages
English (en)
Inventor
David Askin
Kan K Eng
Peter E Maligres
Paul J Reider
Kai Rossen
Ralph P Volante
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22764868&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2167419(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Application granted granted Critical
Publication of ES2167419T3 publication Critical patent/ES2167419T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epoxy Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

UN PROCESO PARA SINTETIZAR EL EPOXIDO DE FORMULA (I) SE COMPONE DE, COMO MINIMO, LA FORMACION DEL REACTIVO ALIL ACETONIDA EN SU FORMA DE HALOHIDRINA, SEGUIDA DE UNA CICLIZACION INDUCIDA DE BASE, EL PRODUCTO EPOXIDO (I) SIENDO UTIL COMO UN INTERMEDIO PARA LA SINTESIS DE LOS INHIBIDORES DE RENINA O PROTEASAS DEL HIV U OTRAS PROTEASAS
ES95911105T 1994-03-04 1995-02-27 Procedimiento de fabricacion de un epoxido. Expired - Lifetime ES2167419T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20607494A 1994-03-04 1994-03-04

Publications (1)

Publication Number Publication Date
ES2167419T3 true ES2167419T3 (es) 2002-05-16

Family

ID=22764868

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95911105T Expired - Lifetime ES2167419T3 (es) 1994-03-04 1995-02-27 Procedimiento de fabricacion de un epoxido.

Country Status (25)

Country Link
EP (1) EP0748319B1 (es)
JP (1) JP3871705B2 (es)
KR (1) KR100387741B1 (es)
CN (1) CN1066728C (es)
AT (1) ATE210662T1 (es)
AU (1) AU690231B2 (es)
BR (1) BR9506977A (es)
CA (1) CA2183976C (es)
CZ (1) CZ291816B6 (es)
DE (1) DE69524578T2 (es)
DK (1) DK0748319T3 (es)
ES (1) ES2167419T3 (es)
FI (1) FI120259B (es)
HR (1) HRP950096B1 (es)
HU (1) HU222750B1 (es)
MX (1) MX9603871A (es)
NZ (1) NZ281866A (es)
PT (1) PT748319E (es)
RO (1) RO117696B1 (es)
RU (1) RU2137769C1 (es)
SK (1) SK283067B6 (es)
TW (1) TW380137B (es)
UA (1) UA45968C2 (es)
WO (1) WO1995023797A1 (es)
YU (1) YU49010B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5728840A (en) * 1994-03-04 1998-03-17 Merck & Co., Inc. Process for making an epoxide
TW415948B (en) * 1995-10-30 2000-12-21 Merck & Co Inc Process for synthesizing epoxide and halohydrin
US5981759A (en) * 1997-06-20 1999-11-09 Merck & Co., Inc. Process for indinavir intermediate
US7687456B2 (en) 2005-11-09 2010-03-30 Proteolix, Inc. Compounds for enzyme inhibition
EP2484688B1 (en) 2006-06-19 2016-06-08 Onyx Therapeutics, Inc. Peptide epoxyketones for proteasome inhibition
MX2010003732A (es) * 2007-10-04 2010-08-09 Onyx Therapeutics Inc Inhibidores de peptido cetona epoxi de proteasa cristalina y la sintesis de ceto-epoxidos de aminoacido.
PE20120059A1 (es) 2008-10-21 2012-02-27 Onyx Therapeutics Inc Combinaciones farmaceuticas con epoxicetonas peptidicas
TWI504598B (zh) 2009-03-20 2015-10-21 Onyx Therapeutics Inc 結晶性三肽環氧酮蛋白酶抑制劑
US8853147B2 (en) 2009-11-13 2014-10-07 Onyx Therapeutics, Inc. Use of peptide epoxyketones for metastasis suppression
US9359398B2 (en) 2010-03-01 2016-06-07 Onyx Therapeutics, Inc. Compounds for immunoproteasome inhibition
CA2798101A1 (en) * 2010-04-30 2011-11-03 Indiana University Research And Technology Corporation Processes for preparing linezolid
US9309283B2 (en) 2012-07-09 2016-04-12 Onyx Therapeutics, Inc. Prodrugs of peptide epoxy ketone protease inhibitors
CN104692987B (zh) * 2015-01-22 2017-05-17 北京大学 卤代醇及其衍生物的廉价高效合成方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2072237A1 (en) * 1991-07-02 1993-01-03 Merck & Co., Inc. Stereoselective production of hydroxyamide compounds from chiral –-amino epoxides
CA2081970C (en) * 1991-11-08 1997-07-08 Joseph P. Vacca Hiv protease inhibitors useful for the treatment of aids

Also Published As

Publication number Publication date
BR9506977A (pt) 1997-09-02
AU690231B2 (en) 1998-04-23
HU9602412D0 (en) 1996-11-28
FI963452A0 (fi) 1996-09-03
YU14595A (sh) 1997-12-05
CA2183976A1 (en) 1995-09-08
CZ291816B6 (cs) 2003-06-18
FI963452L (fi) 1996-09-03
HRP950096B1 (en) 2002-06-30
HRP950096A2 (en) 1997-06-30
RU2137769C1 (ru) 1999-09-20
UA45968C2 (uk) 2002-05-15
EP0748319A1 (en) 1996-12-18
JP3871705B2 (ja) 2007-01-24
NZ281866A (en) 1998-05-27
YU49010B (sh) 2003-04-30
CA2183976C (en) 2005-02-01
JPH09509929A (ja) 1997-10-07
ATE210662T1 (de) 2001-12-15
HUT75611A (en) 1997-05-28
DK0748319T3 (da) 2002-03-18
EP0748319B1 (en) 2001-12-12
KR970701714A (ko) 1997-04-12
DE69524578D1 (de) 2002-01-24
RO117696B1 (ro) 2002-06-28
KR100387741B1 (ko) 2003-10-04
SK112296A3 (en) 1997-02-05
CZ254396A3 (en) 1997-01-15
PT748319E (pt) 2002-05-31
HU222750B1 (hu) 2003-09-29
TW380137B (en) 2000-01-21
DE69524578T2 (de) 2002-07-18
CN1066728C (zh) 2001-06-06
WO1995023797A1 (en) 1995-09-08
FI120259B (fi) 2009-08-31
SK283067B6 (sk) 2003-02-04
CN1146768A (zh) 1997-04-02
AU1882895A (en) 1995-09-18
MX9603871A (es) 1997-07-31

Similar Documents

Publication Publication Date Title
ES2167419T3 (es) Procedimiento de fabricacion de un epoxido.
TR200100623T2 (tr) 5-Tia-w-ikameli fenil-prostaglandin türevleri, bunları üretme yöntemleri ve müessir madde olarak bunları ihtiva eden ilaçlar
ES2071351T3 (es) Un procedimiento para la produccion de 6,12-dihidro-6-hidroxicannabidiol y el uso del mismo para la produccion de trans-delta-9-tetrahidrocannabinol.
ES442997A1 (es) Procedimiento de obtencion de substratos cromogenicos para enzimas.
ES2073422T3 (es) Metodo para fabricar un material metalico.
EA200401398A1 (ru) Замещённые фенилацетамиды и их применение в качестве активаторов глюкокиназы
IT7922047A0 (it) Impianto per la produzione di gascompresso, rispettivamente di energia meccanica.
ES2131830T3 (es) Benzamidinas sustituidas, su preparacion y uso como medicamentos.
ES2087631T3 (es) Procedimiento para la pasivacion de pigmentos metalicos.
IT8021079A0 (it) Metodo di produzione di lampade ascarica, a vapori di mercurio abassa pressione.
IT1111542B (it) Lampada a scarica,a vapori di sodio,ad alta pressione
BR0304213A (pt) Processo para a sìntese industrial de ranelato de estrÈncio e os seus hidratos
IT7821989A0 (it) Processo per la produzione di glicol etilenico.
ES455621A1 (es) Un procedimiento para la preparacion de meta-ariloxibenzal- dehidos.
IT8020133A0 (it) Lampada a scarica, a vapori di mercurio, ad alta pressione
ES2113893T3 (es) Un procedimiento para la produccion de proteinas vegetales hidrolizadas utilizando acido clorhidrico gaseoso y su produccion.
IT1063805B (it) Procedimento per la produzione di glicoli etilenici ad alta purezza
BG43693A3 (bg) Метод за получаване на 6,16-диметилкортикоиди
ES2073501T3 (es) Procedimiento para el tratamiento de laminas de poliolefina.
ES2096811T3 (es) Produccion de aminas alifaticas primarias.
ES2051954T3 (es) 2-aminotiazoles substituidos.
IT7826978A0 (it) Procedimento per la produzione di idrocarburi aromatici ad elevata purezza.
ES2155091T3 (es) Procedimiento para la produccion de inhibidores de la proteasa del vih.
ID22843A (id) Proses untuk n,n,n,n-tetra-(2-hidroksietil)-etilena diamina
ES2102814T3 (es) Preparacion de acidos polioxialquilen-alfa,omega-dicarboxilicos.